Percutaneous coronary intervention for left main stem disease: Impact of diabetes mellitus on mortality

Bilal R Bawamia1, Mohaned Egred2,3, Matthew Jackson1

  • 1Cardiology Department, James Cook University Hospital, Middlesbrough, UK.

Insights

Diabetes mellitus (DM) did not significantly increase 30-day mortality after left main stem (LMS) percutaneous coronary intervention (PCI). However, insulin-treated diabetes (ITDM) was linked to increased long-term mortality in patients undergoing LMS PCI.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Limited real-world data exists on outcomes for diabetic patients undergoing left main stem (LMS) percutaneous coronary intervention (PCI).
  • Understanding the impact of diabetes mellitus (DM) on mortality after LMS PCI is crucial for patient management.

Purpose of the Study:

  • To assess the impact of DM on mortality following LMS PCI.
  • To compare mortality outcomes between non-insulin-treated DM (NITDM) and insulin-treated DM (ITDM) in various clinical settings.

Main Methods:

  • Retrospective analysis of 2,675 patients undergoing unprotected LMS PCI at two high-volume tertiary centers (2003-2017).
  • Data collected on diabetic status, clinical setting, and all-cause mortality at 30 days and up to 36 months post-PCI.

Main Results:

  • DM was not associated with increased 30-day mortality (OR 1.39, p = .15).
  • A borderline association was found between DM and long-term mortality (HR 1.31, p = .05).
  • Insulin-treated DM (ITDM), but not NITDM, was significantly associated with both short- and long-term mortality.

Conclusions:

  • DM generally does not impact 30-day mortality after LMS PCI.
  • Long-term mortality shows a borderline association with DM, primarily driven by insulin-treated patients.
  • The significant impact of DM on mortality outcomes post-LMS PCI is confined to insulin-treated individuals.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
604
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
186
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
174
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
268
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
186
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
276